Background
Currently used techniques to quantify late gadolinium enhancement (LGE) include an intensity threshold 5 standard deviations (5-SD) above normal myocardium and the full width at half maximum (FWHM) of the histogram [1, 2] . Validation of these segmentation schemes can be performed ex vivo using tetrazolium tetrachloride (TTC). However, no analogous gold standard metric exists in vivo. We recently introduced the tractographic propagation angle (PA) [3] , and showed that a PA threshold of 4°in infarcted hearts produces a distribution that corresponds very closely to that of TTC staining [4] . Here, we use PA maps in patients with myocardial infarction (MI) to evaluate the standard FWHM and 5-SD metrics. In addition, we introduce a new metric based on a Gaussian fit of the LGE image histogram.
Methods
Patients with acute MI (n=3) were imaged at the diastolic sweet spot on a 1.5 T scanner with a diffusion-encoded stimulated echo EPI sequence using the following parameters: resolution 2x2x8 mm 3 , b-value of 500 s/mm 2 , 10 diffusion-encoding directions, and 8 averages.
LGE was performed using a 2D inversion recovery gradient echo sequence. Mean diffusivity (MD), fractional anisotropy (FA), helix angle (HA), and PA were calculated from the dyadic diffusion tensor. LGE of 16 short-axis slices were available for analysis. In addition to computing the 5-SD and FWHM, a Gaussian fit of each image histogram was performed and a threshold applied in 10% increments (G10-G100) of the total area.
Results
In normal myocardium PA is typically less than 4°( Figure 1A ). Of all LGE-based metrics, G60 demonstrated the closest relationship to PA ( Figures 1B-D) . 
Conclusions
A Gaussian fit using 60% of the LGE histogram area (G60) improves infarct segmentation and correlates well with a PA threshold of 4°. PA provides valuable information for infarct detection and microstructural characterization of the myocardium, can be assessed in vivo without exogenous contrast, and could prove valuable in a broad range of cardiovascular diseases. 
